Participants in this study will work closely with world-renowned academic researchers.
You can help scientists learn about Alzheimer’s disease and develop solutions, while learning about your own health and risks for Alzheimer’s disease.
Participants Eligible for the AHEAD Study
- Are healthy adults ages 55-80 who may have an increased risk of memory loss associated with Alzheimer’s disease
- Have not been diagnosed with Alzheimer’s disease or another dementia
- Have elevated or intermediate levels of amyloid in their brains determined by brain imaging as part of the study
- Have a close friend or relative who can serve as their study partner
What is “Amyloid”?
- A protein called “amyloid” builds up in the brains of people who have Alzheimer’s disease.
- While not all people with amyloid in their brain will develop Alzheimer’s disease, previous research found that people with normal memory and thinking skills who demonstrate elevated levels of amyloid are at increased risk to develop the symptoms of Alzheimer’s disease.
- In clinical trials, researchers are testing whether investigational medications aimed at decreasing the amyloid build-up in the brain can delay or prevent the onset of memory problems.
What if I do not have Amyloid Build-Up?
Those screened who do not have amyloid build-up detected in their brain are not eligible to participate in the AHEAD Study, but can monitor their own memory performance by enrolling in the Alzheimer Prevention Trials (APT) Webstudy. The “webstudy” is entirely online and for people over the age of 50.